Prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer

Clinics

Volumn 66, Issue 2, 2011, Pages 281-286

  Vaisman, Fernanda ^a   Bulzico, Daniel Alves ^a   Pessoa, Cencita Hosannah Cordeiro Noronha ^a   Bordallo, Maria Alice Neves ^a   de Mendonça, Ullyanov Bezerra Toscano ^a   Dias, Fernando Luiz ^a   Coeli, Claudia Medina ^b   Corbo, Rossana ^a   Vaisman, Mario ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Childhood; Radioactive iodine; Response to therapy; Staging system; Thyroid cancer

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; EPIDEMIOLOGY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METASTASIS; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; THYROID TUMOR; TIME; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PROGNOSIS; THYROID NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955491363     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000200017     Document Type: Article

References (34)

1. Danese D, Gardini A, Farsetti A, Sciacchitano S, Andreoli M, Pontecorvi A. Thyroid carcinoma in children and adolescents. Eur J Pediatr. 1997;156:190-194, doi: 10.1007/s004310050580.
2. Dottorini ME, Vignati A, Mazzucchelli L, Lomuscio G, Colombo L. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med. 1997;38:669-675.
3. Lee YM, Lo CY, Lam KY, Wan KY, Tam PK. Well-differentiated thyroid carcinoma in Hong Kong Chinese patients under 21 years of age: a 35- year experience. J Am Coll Surg. 2002;194:711-716, doi: 10.1016/S1072-7515(02)01139-0.
4. Popovtzer A, Shpitzer T, Bahar G, Feinmesser R, Segal K. Thyroid cancer in children: management and outcome experience of a referral center. Otolaryngol Head Neck Surg. 2006;135:581-584, doi: 10.1016/j.otohns.2006.04.004.
5. Zimmerman D, Hay ID, Gough IR, Goellner JR, Ryan JJ, Grant CS, McConahey WM. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery. 1988; 104:1157-1166.
6. Bal CS, Padhy AK, Kumar A. Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodinedeficient endemic zone. Nucl Med Commun. 2001;22:881-887, doi: 10.1097/00006231-200108000-00006.
7. Spinelli C, Bertocchini A, Antonelli A, Miccoli P. Surgical therapy of the thyroid papillary carcinoma in children: experience with 56 patients, or = 16 years old. J Pediatr Surg. 2004; 39:1500-1505, doi: 10.1016/j.jpedsurg. 2004.06.016.
8. Farahati J, Bucsky P, Parlowsky T, Mäder U, Reiners C. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer, 1997;80:2156-2152, doi: 10. 1002/(SICI)1097-0142(19971201)80:11,2156AID-CNCR16.3.0.CO;2-Y.
9. Borson-Chazot F, Causeret S, Lifante JC, Augros M, Berger N, Peix JL. Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer. World J Surg. 2004;28:1088-1092, doi: 10.1007/s00268-004-7630-y.
10. Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Svec RL, Adair C, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf). 1998; 49:619-628, doi: 10.1046/j.1365-2265.1998. 00584.x.
11. Palmer BA, Zarroug AE, Poley RN, Kollars JP, Moir CR. Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence. J Pediatr Surg. 2005; 40:1284-1288, doi: 10.1016/j.jpedsurg.2005.05.012.
12. Chaukar DA, Rangarajan V, Nair N, Dcruz AK, Nadkarni MS, Pai PS, et al. Pediatric thyroid cancer. J Surg Oncol. 2005; 92:130-133, doi: 10.1002/jso.20339.
13. Jarzab B, Handkiewicz Junak D, Włoch J, Kalemba B, Roskosz J, et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med. 2000;27:833-841, doi: 10.1007/s002590000271.
14. Vassilopoulou-Sellin R, Klein MJ, Smith TH, Samaan NA, Frankenthaler RA, Goepfert H, et al. Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer. 1993;71:1348-1352, doi:10.1002/1097-0142(19930215)71:4,1348::AID-CNCR2820710429.3.0.CO;2-3.
15. Newman KD, Black T, Heller G, Azizkhan RG, Holcomb GW 3rd, Sklar C, et al. Differentiated thyroid cancer: determinants of disease progression in patients,21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg. 1998;227:533-5341, doi: 10.1097/00000658-199804000-00014.
16. Massimino M, Gasparini M, Ballerini E, Del Bo R. Primary thyroid carcinoma in children: a retrospective study of 20 patients. Med Pediatr Oncol.1995;24:13-17, doi: 10.1002/mpo.2950240104.
17. Schlumberger MJ. Papillary and follicular thyroid carcinoma. New Engl J Med. 1998;338:297-306, doi: 10.1056/NEJM199801293380506.
18. Mazzaferri EL & Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418-428, doi: 10.1016/0002-9343(94)90321-2.
19. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK,Sutcliffe SB & Panzarella T. Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med. 1987;83 479-488, doi: 10.1016/0002-9343(87)90758-3.
20. DeGroot LJ, Kaplan EL, McCormick M, Straus FH: Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrino lMetab. 1990;71 414-424, doi: 10.1210/jcem-71-2-414.
21. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP,Johnston DA, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714-720, doi: 10.1210/jc.75.3.714.
22. Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G & Gerstein HC. Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant initial therapy for welldifferentiated thyroid cancer. J Clin Endocrinol Metab. 2004;89:3668-3676, doi: 10.1210/jc.2003-031167.
23. Doi SA, Woodhouse NJ. Initial therapy of the thyroid remnant and 131I dose in differentiated thyroid cancer. Clin Endocrinol (Oxf). 2000;52:765-773, doi: 10.1046/j.1365-2265.2000.01014.x.
24. de Klerk JM, de Keizer B, Zelissen PM, Lips CM, Koppeschaar HP. Fixed dosage of 131I for remnant initial therapy in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy. Nucl Med Commun. 2000; 21:529-532, doi: 10.1097/00006231-200006000-00005.
25. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M. Is diagnostic iodine-131 scanning useful after total thyroid initial therapy for differentiated thyroid cancer? J Clin Endocrinol Metab. 2000;85:175-178,doi: 10.1210/jc.85.1.175.
26. Verburg F A, Keizer B, Lips CJM, Zelissen PMJ and de Klerk JMH Prognostic significance of good response to initial therapy with radioiodine of differentiated thyroid cancer patients. Eur J Endocrinol. 2005;152:33-37, doi: 10.1530/eje.1.01819.
27. International Union Against Cancer (UICC) 2009: ''TNM classification of malignant tumors.''7th ed. New York: Wiley 28. Cady B. Presidential address: beyond risk groups-a new look at differentiated thyroid cancer. Surgery. 1998;124 947-957, doi: 10.1016/S0039-6060(98)70034-0.
28. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050-1057.
29. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2009;19:1167-1214, doi: 10.1089/thy.2009.0110.
30. Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res. 2009;156:167-172, doi: 10.1016/j.jss.2009.03.098.
31. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Mang O, et al. Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine. Ped Blood Cancer. 2004a 42:176-183, doi:10.1002/pbc.10410.
32. Jarzab B, Handkiewicz-Junak D, J Włoch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review Endocrine-Related Cancer 2005;12:773-803.
33. Wada N, Sugino K, Mimura T, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K et al. Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival BMC Cancer. 2009;9:306-308.
34. Hay ID, Gonzalez-Lousada T, Reunalda MS, Honetschalger JA, Richards ML, Thompson GB. Long-Term Outcome in 215 Children and Adolescents with Papillary Thyroid cancer Treated During 1940 though 2008. World J Surg. 2010;34:1192-1202, doi: 10.1007/s00268-009-0364-0.